Skip to main content
SpringerLink
Log in

Kein Nachweis einer reduzierten Spättoxizität durch Dosisreduktion im elektiven Lymphknotenbereich in der primären Radiochemotherapie von Kopf-Hals-Tumoren

No evidence for reduced late toxicity with dose reduction in the elective lymph node region in primary radiochemotherapy of head and neck tumors

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bedi M, Firat S, Semenenko VA et al (2012) Elective lymph node irradiation with intensity-modulated radiotherapy: is conventional dose fractionation necessary? Int J Radiat Oncol Biol Phys 83:e87–e92

    Article  PubMed  Google Scholar 

  2. Nuyts S, Lambrecht M, Duprez F et al (2013) Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity. Radiother Oncol 109:323–329

    Article  PubMed  Google Scholar 

  3. Garattini S, Bertelè V (2007) Non-inferiority trials are unethical because they disregard patients’ interests. Lancet 370:1875–1877

    Article  PubMed  Google Scholar 

  4. Salama JK, Stenson KM, Kistner EO et al (2008) Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels. Ann Oncol 19:1787–1794

    Article  PubMed  CAS  Google Scholar 

  5. Langendijk JA, Doornaert P, Rietveld DH et al (2009) A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer. Radiother Oncol 90:189–195

    Article  PubMed  Google Scholar 

  6. Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL et al (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7–16

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Carl Gustav Carus, Technische Univeristät Dresden, Fetscherstraße 74, 01307, Dresden, Deutschland

    Mohammad Hreib &  Mechthild Krause

Authors
  1. Mohammad Hreib
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mechthild Krause
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mechthild Krause.

Ethics declarations

Interessenkonflikt

M. Hreib und M. Krause geben an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation

Nuyts S, Lambrecht M, Duprez F, et al (2013) Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity. Radiother Oncol 109:323–329

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hreib, M., Krause, M. Kein Nachweis einer reduzierten Spättoxizität durch Dosisreduktion im elektiven Lymphknotenbereich in der primären Radiochemotherapie von Kopf-Hals-Tumoren. Strahlenther Onkol 194, 697–698 (2018). https://doi.org/10.1007/s00066-018-1312-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-018-1312-4

Search

Navigation